International Bio Recovery Corporation announces private placement
TSX Venture Exchange symbol: IBR
Each unit will consist of one share and one warrant exercisable at
This private placement represents a significant addition to the capitalization of the Company and is supported by a new major investor and current shareholders.
The proceeds of the financing will be used to put in place production capacity to allow commercial marketing of end products that will establish market presence and pricing and to enhance the Company's research and development capabilities.
The private placement is subject to the receipt of all necessary approvals, including approval of the TSX Venture Exchange.
The common share units have not and will not be registered under
About IBR
Located in North
THE TSX VENTURE EXCHANGE DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR THE ACCURACY OF THIS RELEASE.
For further information: For further information: Ben Van Dyk, Chairman of the Board, IBR, (604) 924-1023 ext 304, (604) 924-1043 fax, [email protected]; Henry J. Bow, President & CEO, IBR, (604) 924-1023 ext 309, (604) 924-1043 fax, [email protected]
Share this article